Dysmenorrhea Treatment Market
Market research report analyzing sales of dysmenorrhea treatment market, demand of dysmenorrhea treatment, and trend analysis of dysmenorrhea treatment market till 2032
Dysmenorrhea Treatment Market By Product Type, End-User & Region - Forecast 2022 – 2032
Dysmenorrhea Treatment Market Snapshot (2022-2032)
[298 Pages Report] The global dysmenorrhea treatment market is expected to be valued at US$ 5937.8 Million in 2022, and is projected to reach US$ 13179.8 Million by 2032. A CAGR worth 8.3% is expected for the market during the 2022-2032 forecast period.
Dysmenorrhea is a clinical term for menstrual cramps in which a woman experiences severe pain or cramps in her abdominal area that may spread to her lower legs and back. Most women begin suffering dysmenorrhea throughout adolescence, generally after four to five years of first menstrual cycle.
Prostaglandins are substances that are produced in the uterine lining during menstruation. These prostaglandins generate uterine muscular spasms, which cause discomfort and reduce blood supply and oxygen to the uterus. Menstrual problems can be caused by a wide range of underlying conditions.
Lifestyle modifications, changes in the environment, and food preferences all have a significant influence on human bodies, which has raised the occurrence of dysmenorrhea amongst women. The increased frequency of dysmenorrhea has led to increased health consciousness among women to treat the illness, which is projected to drive market growth.
The increased consumer awareness of dysmenorrhea therapy, as well as the low cost of over-the-counter medications, are two important factors driving growth in the dysmenorrhea treatment market. The increased usage of drugs to relieve pain during menstruation, in turn, drives the growth of the worldwide dysmenorrhea treatment market.
Additionally, throughout the forecast period, the increase in technological improvement in the healthcare industry is likely to fuel the growth of the dysmenorrhea treatment market. However, long-term treatment side effects and issues, the high morbidity of menstrual cramps leading to inadequate treatments, and traditional family values are expected to stymie the growth of the dysmenorrhea treatment industry.
|
Report Attribute |
Details |
|
Expected Market Value (2022) |
US$ 5937.8 Million |
|
Projected Forecast Value (2032) |
US$ 13179.8 Million |
|
Anticipated Growth Rate (2022-2032) |
8.3% |
Let us know your requirement to get
100% FREE customization
What Are The Major Factors Boosting The Dysmenorrhea Treatment Market?
The growing healthcare spending, which aids in the improvement of infrastructure, is a crucial element driving the development rate of the dysmenorrhea treatment market. Furthermore, numerous government organizations intend to improve healthcare infrastructure by boosting financing, which would have an impact on market dynamics.
People's changing lifestyles are expected to have an impact on market dynamics throughout the projected period of 2022-2032. Changing lifestyles, along with bad eating habits, have a significant influence on the human body. As a result, the prevalence of dysmenorrhea/menstrual cramps among women has increased. Climate factors are also thought to increase the likelihood of menstruation cramps.
Furthermore, a growing number of government measures to raise awareness and increase the aging population would result in the dysmenorrhea treatment market. Along with this, increased disposable income and urbanization will boost the market's growth rate.
What Are The Factors Hindering The Dysmenorrhea Treatment market?
The high cost of care, on the other hand, will impede the growth rate of the dysmenorrhea treatment market during the forecast period of 2022-2032. The dysmenorrhea treatment market will face challenges due to a lack of healthcare infrastructure in emerging nations and a stringent regulatory environment. Furthermore, a lack of public awareness and inadequate reimbursement policies may hinder and impede market expansion during the projection period of 2022-2032.
Additionally, challenges related with long-term care and other side effects and issues, the high morbidity of menstrual cramps due to insufficient treatments, and traditional family values are expected to stymie the growth of the dysmenorrhea treatment market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Is The Outlook Of The Disease Segment Of The Dysmenorrhea Treatment Market?
During the projected period of 2022-2032, the endometriosis segment is expected to gain a global market share of 35% during the forecast period. The rising prevalence of endometriosis is projected to drive the dysmenorrhea treatment market forward.
The global prevalence of disorders such as endometriosis, the primary cause of secondary dysmenorrhea, is also increasing. Endometriosis affects an estimated 1 in 10 women throughout their reproductive years, or around 176 million people globally, according to an article titled "Understanding Endometriosis - the Basics" published in July 2021. This element is predicted to have a substantial influence on market growth. As a result of the aforementioned causes, the nonsteroidal anti-inflammatory medicines category is predicted to considerably contribute to market growth.
What Is The Outlook Of The North American Dysmenorrhea Treatment Market?
In terms of market share and revenue, the North American market is expected to be the dominant market for dysmenorrhea treatments during the projection period of 2022-2032. The analysts at Future Market Insights predict that by 2022, the market of dysmenorrhea treatments in North America is expected to acquire a global market size of 29%.
This will maintain its supremacy throughout the projected period. This is because technological innovation and increased healthcare spending will drive the market's growth rate in this area even faster. Furthermore, the presence of significant key competitors and rising pharmaceutical consumption will drive the market's development rate in this area even faster.
Furthermore, a growth in R&D procedures for generating new pharmaceuticals and assessing the potential of existing therapies may improve the market under consideration. For example, a January 2019 research titled "Continuous vs. cyclic combined hormonal contraceptives for the treatment of dysmenorrhea: a comprehensive review" found that flexible/extended combined hormonal contraceptives (CHC) culminated in four fewer days of dysmenorrhea than the cyclic regimen. Such research projects are likely to considerably contribute to the market's growth.
A unified Market Research Subscription Platform, built for today's disparate research needs.
How Is The European Market Driving Demand For Dysmenorrhea Treatments?
By 2022, Europe will hold approximately 24% of the global market share. This region is expected to be one of the fastest growing markets for the dysmenorrhea treatment during the forecast period, 2022-2032.
The increasing number of R&D activities is driving the market's expansion. This would give advantageous chances for the expansion of the dysmenorrhea treatments market. Leading corporations are investing in research and development. This brings up a lot of market opportunities.
What Can Be Expected From The APAC Region During The Forecast Period?
The Asia Pacific region is expected to develop at the fastest CAGR during the forecast period.
This is owing to a rise in the prevalence of Dysmenorrhea and menstrual health issues in this region for treatment. Furthermore, the expansion of healthcare infrastructure and growing government efforts would accelerate the market's growth rate in this area.
Market Competition
The key players of this market include Novartis Pharmaceuticals Corporation, Merck, Inc., Bayer Schering Pharma AG, Vanita Therapeutics, Nua, Cora, Alvogen, Pfizer, Inc., Roche Laboratories, Taj Pharmaceuticals, Ltd., Sanofi, Terramedic, Inc.
- Nua announced the release of Cramp Comfort, a first-of-its-kind period pain relief solution, in December 2020. Nua, a women's health startup, has released a revolutionary self-heating patch that can deliver up to 8 hours of heat to alleviate period discomfort. Cramp Comfort is made completely of natural ingredients and was created after considerable research and a full grasp of client expectations. The price of a pack of three heat patches is INR 299.
- Cora® debuted their fresh comfort-focused brand image, feel, and identity in 2022. Moreover, to rebrand, the company has expanded its product line with new wellness products to meet the needs of a wide range of consumers. The Comfort Fit TamponTM, The Got-You-Covered LinerTM, The Peace-of-Mind PadTM, and The Perfect Fit DiscTM are among the new product names.
Start-up scenario
- Ovira, an Australian start-up, has released its flagship product. It is a TENS (Transcutaneous Electrical Nerve Stimulation) device, which operates by sending a mild electrical current via two compression pads positioned over the love handles, which contain the nerve roots that provide the sensory fibres to the uterus. Once implanted, the stimulation inhibits pain signals from reaching the brain, allowing uterine muscle relaxation and providing pain relief.
- Gynica is a FemTech startup based in Israel. It is responsible for the creation of cannabis-based treatments for women's reproductive health. Gynica is a medical firm that is studying and developing marijuana treatments for gynecological disorders and symptoms. They are members of Station F's FemTech Cohort.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 8.3% from 2022 to 2032 |
|
Market value in 2022 |
US$ 5937.8 Million |
|
Market value in 2032 |
US$ 13179.8 Million |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2017-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
USD Million for Value |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customisation Scope |
Available on Request |
Key Segments Profiled In The Global Dysmenorrhea Treatment Market
Dysmenorrhea Treatment Market By Diseases:
- Primary Dysmenorrhea
- Secondary Dysmenorrhea
- Endometriosis
- Adenomyosis
- Uterine Myomas
- Endometrial Polyps
- Cervical Stenosis
- Obstructive Malformations Of Genital Tract
Dysmenorrhea Treatment Market By Therapeutic Class:
- Non-Hormonal Medical Treatment
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
- Non-Selective Nsaids
- Cox-2 Inhibitors
- Transdermal Glyceryl Trinitrate
- Over-The-Counter (Otc) Medications
- Hormonal Medicine Treatment
- Combined Oral Contraceptive
- Progestin Regimens
- Levonorgestrel Intrauterine System (LN-IUS)
- Surgical Options
- Laparoscopy
- Hysterectomy
- Presacral Neurectomy
- Laparoscopic Uterosacral Nerve Ablation (LUNA)
- Intrauterine Device (IUD)
Dysmenorrhea Treatment Market By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- APAC
- Japan
- MEA
Frequently Asked Questions
What is the anticipated growth of the global dysmenorrhea treatment market from 2022-to 2032?
The global dysmenorrhea treatment market is expected to grow at a 8.3% CAGR and secure US$ 13179.8 Million by 2032.
Which region is expected to be the most lucrative for the dysmenorrhea treatment market?
North America is expected to be the fastest growing market for dysmenorrhea treatments during the forecast period and is expected to acquire a market share of 29% in 2022.
Which are some eminent players of the global dysmenorrhea treatment market?
Novartis Pharmaceuticals Corporation, Merck, Inc., Bayer Schering Pharma AG, Vanita Therapeutics, Alvogen, Pfizer, Inc., Nua, Cora, Roche Laboratories, Taj Pharmaceuticals, Ltd., Sanofi, Terramedic, Inc. are some of the known players in the dysmenorrhea treatment market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Disease Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Disease Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Disease Type launches 5.2.2. Cost of Disease Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Dysmenorrhea Treatment Market - Pricing Analysis 6.1. Regional Pricing Analysis By Disease Type 6.2. Pricing Break-up 6.2.1. Manufacturer Level Pricing 6.2.2. Distributor Level Pricing 6.3. Global Average Pricing Analysis Benchmark 7. Global Dysmenorrhea Treatment Market Value Analysis 2016–2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2016–2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032, by Disease Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Disease Types & Services, 2016–2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2022-2032 8.3.1. Primary Dysmenorrhea 8.3.2. Secondary Dysmenorrhea 8.3.3. Endometriosis 8.3.4. Adenomyosis 8.3.5. Uterine Myomas 8.3.6. Endometrial Polyps 8.3.7. Cervical Stenosis 8.3.8. Obstructive Malformations of Genital Tract 8.4. Market Attractiveness Analysis By Disease Type 9. Global Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032, by Therapeutic Class 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Class , 2016–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Class , 2022-2032 9.3.1. Non-Hormonal Medical Treatment 9.3.1.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 9.3.1.1.1. Non-Selective NSAIDs 9.3.1.1.2. Cox-2 Inhibitors 9.3.1.1.3. Transdermal Glyceryl Trinitrate 9.3.1.1.4. Over-the-Counter (OTC) Medications 9.3.2. Hormonal Medicine Treatment 9.3.2.1. Combined Oral Contraceptive 9.3.2.2. Progestin Regimens 9.3.2.3. Levonorgestrel Intrauterine System (LN-IUS) 9.3.3. Surgical Options 9.3.3.1. Laparoscopy 9.3.3.2. Hysterectomy 9.3.3.3. Presacral Neurectomy 9.3.3.4. Laparoscopic Uterosacral Nerve Ablation (NUSA) 9.3.3.5. Intrauterine Device (IUD) 9.4. Market Attractiveness Analysis By Therapeutic Class 10. Global Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2021 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.3.1. By Country 11.3.1.1. U.S. 11.3.1.2. Canada 11.3.2. By Disease Type 11.3.3. By Therapeutic Class 11.4. Market Attractiveness Analysis 11.5. Key Market Participants - Intensity Mapping 11.6. Drivers and Restraints - Impact Analysis 12. Latin America Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Disease Type 12.3.3. By Therapeutic Class 12.4. Market Attractiveness Analysis 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Europe Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. Italy 13.3.1.3. France 13.3.1.4. U.K. 13.3.1.5. Spain 13.3.1.6. Russia 13.3.1.7. Rest of Europe 13.3.2. By Disease Type 13.3.3. By Therapeutic Class 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. South Asia Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Indonesia 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Disease Type 14.3.3. By Therapeutic Class 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. East Asia Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.1.4. Rest of East Asia 15.3.2. By Disease Type 15.3.3. By Therapeutic Class 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. Oceania Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Disease Type 16.3.3. By Therapeutic Class 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Middle East and Africa Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. South Africa 17.3.1.3. Rest of Middle East and Africa 17.3.2. By Disease Type 17.3.3. By Therapeutic Class 17.4. Market Attractiveness Analysis 17.5. Drivers and Restraints - Impact Analysis 18. Key and Emerging Countries Dysmenorrhea Treatment Market Analysis 2016–2021 and Forecast 2022-2032 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. U.S. Dysmenorrhea Treatment Market Analysis 18.2.1. By Disease Type 18.2.2. By Therapeutic Class 18.3. Canada Dysmenorrhea Treatment Market Analysis 18.3.1. By Disease Type 18.3.2. By Therapeutic Class 18.4. Mexico Dysmenorrhea Treatment Market Analysis 18.4.1. By Disease Type 18.4.2. By Therapeutic Class 18.5. Brazil Dysmenorrhea Treatment Market Analysis 18.5.1. By Disease Type 18.5.2. By Therapeutic Class 18.6. U.K. Dysmenorrhea Treatment Market Analysis 18.6.1. By Disease Type 18.6.2. By Therapeutic Class 18.7. Germany Dysmenorrhea Treatment Market Analysis 18.7.1. By Disease Type 18.7.2. By Therapeutic Class 18.8. France Dysmenorrhea Treatment Market Analysis 18.8.1. By Disease Type 18.8.2. By Therapeutic Class 18.9. Italy Dysmenorrhea Treatment Market Analysis 18.9.1. By Disease Type 18.9.2. By Therapeutic Class 18.10. Spain Dysmenorrhea Treatment Market Analysis 18.10.1. By Disease Type 18.10.2. By Therapeutic Class 18.11. BENELUX Dysmenorrhea Treatment Market Analysis 18.11.1. By Disease Type 18.11.2. By Therapeutic Class 18.12. Russia Dysmenorrhea Treatment Market Analysis 18.12.1. By Disease Type 18.12.2. By Therapeutic Class 18.13. China Dysmenorrhea Treatment Market Analysis 18.13.1. By Disease Type 18.13.2. By Therapeutic Class 18.14. Japan Dysmenorrhea Treatment Market Analysis 18.14.1. By Disease Type 18.14.2. By Therapeutic Class 18.15. South Korea Dysmenorrhea Treatment Market Analysis 18.15.1. By Disease Type 18.15.2. By Therapeutic Class 18.16. India Dysmenorrhea Treatment Market Analysis 18.16.1. By Disease Type 18.16.2. By Therapeutic Class 18.17. ASEAN Dysmenorrhea Treatment Market Analysis 18.17.1. By Disease Type 18.17.2. By Therapeutic Class 18.18. Australia Dysmenorrhea Treatment Market Analysis 18.18.1. By Disease Type 18.18.2. By Therapeutic Class 18.19. New Zealand Dysmenorrhea Treatment Market Analysis 18.19.1. By Disease Type 18.19.2. By Therapeutic Class 18.20. GCC Countries Dysmenorrhea Treatment Market Analysis 18.20.1. By Disease Type 18.20.2. By Therapeutic Class 18.21. Turkey Dysmenorrhea Treatment Market Analysis 18.21.1. By Disease Type 18.21.2. By Therapeutic Class 18.22. South Africa Dysmenorrhea Treatment Market Analysis 18.22.1. By Disease Type 18.22.2. By Therapeutic Class 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Disease Type foot print by Players 19.4.3. Channel Foot Print by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep dive 20.3.1. Novartis Pharmaceutical Corporation 20.3.1.1. Overview 20.3.1.2. Disease Type Portfolio 20.3.1.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.1.4. Sales Footprint 20.3.1.5. Strategy Overview 20.3.2. Merck Inc. 20.3.2.1. Overview 20.3.2.2. Disease Type Portfolio 20.3.2.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.2.4. Sales Footprint 20.3.2.5. Strategy Overview 20.3.3. Bayer AG 20.3.3.1. Overview 20.3.3.2. Disease Type Portfolio 20.3.3.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.3.4. Sales Footprint 20.3.3.5. Strategy Overview 20.3.4. Vanita Therapeutics 20.3.4.1. Overview 20.3.4.2. Disease Type Portfolio 20.3.4.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.4.4. Sales Footprint 20.3.4.5. Strategy Overview 20.3.5. Alvogen 20.3.5.1. Overview 20.3.5.2. Disease Type Portfolio 20.3.5.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.5.4. Sales Footprint 20.3.5.5. Strategy Overview 20.3.6. Pfizer Inc. 20.3.6.1. Overview 20.3.6.2. Disease Type Portfolio 20.3.6.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.6.4. Sales Footprint 20.3.6.5. Strategy Overview 20.3.7. Roche Laboratories 20.3.7.1. Overview 20.3.7.2. Disease Type Portfolio 20.3.7.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.7.4. Sales Footprint 20.3.7.5. Strategy Overview 20.3.8. Taj Pharmaceuticals Ltd. 20.3.8.1. Overview 20.3.8.2. Disease Type Portfolio 20.3.8.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.8.4. Sales Footprint 20.3.8.5. Strategy Overview 20.3.9. Sanofi 20.3.9.1. Overview 20.3.9.2. Disease Type Portfolio 20.3.9.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.9.4. Sales Footprint 20.3.9.5. Strategy Overview 20.3.10. Terramedic Inc. 20.3.10.1. Overview 20.3.10.2. Disease Type Portfolio 20.3.10.3. Profitability by Market Segments (Disease Type/Channel/Region) 20.3.10.4. Sales Footprint 20.3.10.5. Strategy Overview 21. Assumptions and Acronyms Used 22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Dysmenorrhea Treatment Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 02: Global Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 03: Global Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 04: Global Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Region Table 05: North America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 06: North America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 07: North America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 08: Latin America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 09: Latin America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 10: Latin America Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 11: Europe Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 12: Europe Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 13: Europe Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 14: South Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 15: South Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 16: South Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 17: East Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 18: East Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 19: East Asia Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 20: Oceania Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 21: Oceania Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 22: Oceania Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class Table 23: Middle East and Africa Dysmenorrhea Treatment Market Value (US$ Mn) Analysis 2016-2021 and Forecast 2022–2032, By Country Table 24: Middle East and Africa Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Disease Type Table 25: Middle East and Africa Dysmenorrhea Treatment Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2032, By Therapeutic Class
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Dysmenorrhea Treatment Market Volume (in 000' Units) Analysis, 2016-2021 Figure 02: Global Dysmenorrhea Treatment Market Volume Forecast (in 000' Units), 2022-2032 Figure 03: Dysmenorrhea Treatment Pricing Analysis (US$) Per Disease Type, By Region, 2021 Figure 04: Dysmenorrhea Treatment Pricing Analysis (US$) Per Disease Type, By Region, 2021 Figure 05: Global Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 06: Global Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 07: Global Dysmenorrhea Treatment Market Absolute $ Opportunity, 2022-2032 Figure 08: Global Dysmenorrhea Treatment Market Share Analysis (%), By Disease Type, 2022-2032 Figure 09: Global Dysmenorrhea Treatment Market Y-o-Y Analysis (%), By Disease Type, 2022-2032 Figure 10: Global Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 11: Global Dysmenorrhea Treatment Market Share Analysis (%), By Therapeutic Class, 2022-2032 Figure 12: Global Dysmenorrhea Treatment Market Y-o-Y Analysis (%), By Therapeutic Class, 2022-2032 Figure 13: Global Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 14: Global Dysmenorrhea Treatment Market Share Analysis (%), By Region, 2022-2032 Figure 15: Global Dysmenorrhea Treatment Market Y-o-Y Analysis (%), By Region, 2022-2032 Figure 16: Global Dysmenorrhea Treatment Market Attractiveness Analysis by Region, 2022-2032 Figure 17: North America Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 18: North America Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 19: North America Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 20: North America Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 21: North America Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 22: North America Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 23: North America Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 24: North America Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 25: Latin America Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 26: Latin America Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 27: Latin America Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 28: Latin America Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 29: Latin America Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 30: Latin America Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 31: Latin America Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 32: Latin America Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 33: Europe Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 34: Europe Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 35: Europe Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 36: Europe Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 37: Europe Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 38: Europe Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 39: Europe Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 40: Europe Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 41: South Asia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 42: South Asia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 43: South Asia Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 44: South Asia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 45: South Asia Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 46: South Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 47: South Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 48: South Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 49: East Asia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 50: East Asia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 51: East Asia Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 52: East Asia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 53: East Asia Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 54: East Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 55: East Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 56: East Asia Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 57: Oceania Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 58: Oceania Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 59: Oceania Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 60: Oceania Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 61: Oceania Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 62: Oceania Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 63: Oceania Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 64: Oceania Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 65: Middle East and Africa Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 66: Middle East and Africa Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 67: Middle East and Africa Dysmenorrhea Treatment Market Value Share, By Country, 2022 (E) Figure 68: Middle East and Africa Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2016-2021 Figure 69: Middle East and Africa Dysmenorrhea Treatment Market Value Forecast (US$ Mn), 2022-2032 Figure 70: Middle East and Africa Dysmenorrhea Treatment Market Attractiveness Analysis by Disease Type, 2022-2032 Figure 71: Middle East and Africa Dysmenorrhea Treatment Market Attractiveness Analysis by Therapeutic Class, 2022-2032 Figure 72: Middle East and Africa Dysmenorrhea Treatment Market Attractiveness Analysis by Country, 2022-2032 Figure 73: U. S. Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 74: U. S. Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 75: U. S. Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 76: Canada Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 77: Canada Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 78: Canada Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 79: Mexico Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 80: Mexico Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 81: Mexico Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 82: Brazil Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 83: Brazil Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 84: Brazil Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 85: U. K. Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 86: U. K. Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 87: U. K. Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 88: Germany Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 89: Germany Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 90: Germany Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 91: France Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 92: France Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 93: France Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 94: Italy Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 95: Italy Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 96: Italy Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 97: Spain Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 98: Spain Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 99: Spain Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 100: Russia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 101: Russia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 102: Russia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 103: China Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 104: China Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 105: China Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 106: Japan Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 107: Japan Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 108: Japan Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 109: South Korea Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 110: South Korea Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 111: South Korea Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 112: India Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 113: India Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 114: India Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 115: ASEAN Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 116: ASEAN Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 117: ASEAN Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 118: Australia Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 119: Australia Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 120: Australia Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 121: New Zealand Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 122: New Zealand Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 123: New Zealand Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 124: GCC Countries Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 125: GCC Countries Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 126: GCC Countries Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 127: Turkey Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 128: Turkey Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 129: Turkey Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E) Figure 130: South Africa Dysmenorrhea Treatment Market Value Analysis (US$ Mn), 2022 & 2032 Figure 131: South Africa Dysmenorrhea Treatment Market Value Share, By Disease Type, 2022 (E) Figure 132: South Africa Dysmenorrhea Treatment Market Value Share, By Therapeutic Class, 2022 (E)
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
